Jinling Pharmaceutical Co.,Ltd.’s Net Profit Rose 24.6% in First Half of 2023

Jinling Pharmaceutical Co.,Ltd. (金陵药业股份有限公司) (000919.SZ) reported a net profit of 84.9 million yuan in the first half of 2023, up 24.6% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 6.6% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 847.6 million yuan in total liabilities, with a liability-to-asset ratio of 18.6%.